Medicine and Dentistry
Wet Macular Degeneration
100%
Visual Acuity
81%
Vitrectomy
75%
Macular Hole
66%
Ranibizumab
65%
Pars Plana Vitrectomy
51%
Brachytherapy
51%
Age Related Macular Degeneration
50%
Optical Coherence Tomography
46%
Systematic Review
44%
Diabetic Retinopathy
43%
Best Corrected Visual Acuity
38%
Vasculotropin
37%
Ocriplasmin
34%
Vitreoretinal Surgery
32%
Randomized Controlled Trial
30%
Retinal Detachment
30%
Stereotactic Radiotherapy
28%
Prevalence
28%
Bleeding
27%
Ophthalmology
24%
Intravitreal Administration
23%
Meta-Analysis
23%
Impaired Glucose Tolerance
23%
Retreatment
22%
Arm
21%
Tissue Plasminogen Activator
21%
Trypan Blue
20%
Vitreous
20%
Cataract Surgery
20%
Adverse Event
19%
Maculopathy
18%
Retinal Implant
18%
Diabetic Macular Edema
18%
Uveal Effusion Syndrome
18%
Retinal Break
17%
Aflibercept
17%
Retinopathy
17%
Clinical Trial
16%
Vital Stain
16%
Indocyanine Green
16%
Diabetes
16%
Albumin
15%
Peroperative Complication
15%
Radiation Therapy
15%
Sclera
15%
Diabetes Mellitus
14%
Maturity Onset Diabetes of the Young
14%
Cataract
14%
Epiretinal Membrane
14%
Pharmacology, Toxicology and Pharmaceutical Science
Wet Macular Degeneration
73%
Ranibizumab
57%
Retina Macula Hole
41%
Ocriplasmin
40%
Vasculotropin
35%
Randomized Controlled Trial
27%
Age Related Macular Degeneration
25%
Tissue Plasminogen Activator
18%
Bleeding
18%
Indocyanine Green
18%
Aflibercept
17%
Visual Pigment
16%
Monotherapy
16%
Adverse Event
15%
Diabetic Retinopathy
15%
Prevalence
15%
Trypan Blue
12%
Clinical Trial
10%
Taurine
10%
Chitosan
10%
Intravitreal Administration
9%
Rapamycin
9%
Diabetic Macular Edema
9%
Impaired Glucose Tolerance
9%
Retinopathy
8%
Bevacizumab
8%
Epiretinal Membrane
8%
Strontium 90
7%
Macrogol
7%
Clinical Study
6%
Elimination
6%
Diseases
6%
Isotopes of Potassium
6%
Vasculotropin C
6%
Retina Maculopathy
6%
Cell Culture
6%
Alteplase
6%
Combination Therapy
5%
Cotransporter
5%
Yttrium 90
5%
Fluorescein Isothiocyanate
5%
Visual Impairment
5%
Nursing and Health Professions
Ocriplasmin
32%
Retina Macula Hole
23%
Visual Acuity
16%
Confidence Interval
12%
National Eye Institute Visual Function Questionnaire
10%
Syndrome
9%
Effusion
9%
Brachytherapy
9%
Vitrectomy
9%
Quality of Life
8%
Albumin
7%
Wet Macular Degeneration
7%
Odds Ratio
7%
Intravitreal Drug Administration
7%
Indocyanine Green
6%
Epiretinal Membrane
6%
Minimal Clinically Important Difference
6%
Pars Plana Vitrectomy
5%
Nursing Staff
5%
Medical Staff
5%
Non Insulin Dependent Diabetes Mellitus
5%
Visual Pigment
5%